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RIG-I is a cytosolic pathogen recognition receptor
that initiates immune responses against RNA viruses.
Upon viral RNA recognition, antiviral signaling
requires RIG-I redistribution from the cytosol to
membranes where it binds the adaptor protein,
MAVS. Here we identify the mitochondrial targeting
chaperone protein, 14-3-3ε, as a RIG-I-binding
partner and essential component of a translocation
complex or ‘‘translocon’’ containing RIG-I, 14-3-3ε,
and the TRIM25 ubiquitin ligase. TheRIG-I translocon
directs RIG-I redistribution from the cytosol to
membranes where it mediates MAVS-dependent
innate immune signaling during acute RNA virus
infection. 14-3-3ε is essential for thestable interaction
of RIG-I with TRIM25, which facilitates RIG-I ubiquiti-
nation and initiation of innate immunity against hepa-
titis C virus and other pathogenic RNA viruses. Our
results define 14-3-3ε as a key component of a RIG-I
translocon required for innate antiviral immunity.
INTRODUCTION
Retinoic acid-inducible gene I (RIG-I) plays a major role in path-
ogen recognition and intracellular signaling of innate immunity
that initiates the immune response to RNA virus infection. In
particular, RIG-I is essential for resistance to hepatitis C virus
(HCV) infection (Gale and Foy, 2005). During acute HCV infec-
tion, RIG-I recognizes and binds to the polyuridine/cytosine
(poly-U/UC) motif of the HCV RNA, thus signaling an innate
immune response that restricts hepatocyte permissiveness for
infection (Loo et al., 2006). Viral control of these processes
supports chronic HCV infection in nearly 200 million people,
thus marking RIG-I regulation of hepatic defenses as a critical
determinant impacting HCV infection and immunity (Liu and
Gale, 2010; Sumpter et al., 2005).
RIG-I is anRNAhelicaseencoding tandemamino-terminal cas-
pase activation and recruitment domains (CARDs). RIG-I func-
tions as a cytosolic pathogen recognition receptor (PRR) (Loo
and Gale, 2011) and mediates immune signaling after binding to528 Cell Host & Microbe 11, 528–537, May 17, 2012 ª2012 Elsevier Ipathogen-associated molecular pattern (PAMP) motifs within
viral RNA that accumulate during acute infection. RIG-I recog-
nizes 50 triphosphate (50-ppp), double-stranded RNA, and poly-
U/UC motifs as nonself PAMPs through the actions of its
repressor domain (RD) (Cui et al., 2008; Saito et al., 2007), thus
releasing it from autorepression and resulting in its signaling acti-
vation (Jianget al., 2011). ActiveRIG-I thenmediatesdownstream
signaling by binding to the adaptor protein, MAVS, located on the
outer membrane of themitochondria, peroxisomes, and onmito-
chondria-associated membrane (MAM), the last being a subdo-
main of the ER and the main site of intracellular innate immune
and inflammatory signaling (Dixit et al., 2010; Horner et al.,
2011;Zhouetal., 2011).RIG-Ibinds toMAVSthroughCARD inter-
actions. This process results in establishment of a MAVS signal-
osome that drives the activation of IRF-3 and NF-kB, resulting
in the expression of IFN-b and a variety of antiviral and immuno-
modulatory genes that confer antiviral defense and that regulate
immunity to infection (Loo and Gale, 2011). To initiate immune
signaling, RIG-I must traverse the cytoplasm and relocalize to
the MAM compartment for MAVS binding (Horner et al., 2011).
This process is dependent upon K63-linked ubiquitination of
RIG-I on K172R by the E3 ubiquitin ligase tripartite motif-contain-
ing protein 25 (TRIM25). RIG-I interaction with TRIM25 and redis-
tribution to membrane compartments represents a major step in
immune signaling, but how these processes are directed to
trigger innate immunity has not been defined (Gack et al., 2007).
Here we identify 14-3-3ε as a RIG-I binding protein and essential
chaperone of a translocation complex or ‘‘RIG-I translocon’’ con-
taining RIG-I, 14-3-3ε, and TRIM25 (Dougherty and Morrison,
2004; Gack et al., 2008) that directs RIG-I redistribution from
the cytosol to the membrane for MAVS interaction and immune
signalingduringacuteRNAvirus infection.Weshowthat inhuman
hepatocytes translocon assembly is controlled by the RIG-I RD
and induced within minutes of HCV PAMP RNA-ligand binding
by RIG-I. Thus, approaches tomodulate RIG-I translocon activity
may offer therapeutic strategies to suppress virus infection.
RESULTS
RIG-I Undergoes Cytosol-to-Membrane Translocation
during Acute Virus Infection
We conducted membrane flotation by sucrose gradient centrifu-
gation of human hepatoma (Huh7) cell extracts to separatenc.
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of protein localization. The distribution of endogenous RIG-I,
tubulin (a cytoplasmic marker protein), and protein markers of
ER (calnexin), MAM (MFN2), and outer- (VDAC) and inner-
(Cox-1) mitochondrial membrane were then examined in the
resulting cellular fractions. To assess RIG-I distribution during
acute virus infection, Huh7 cells were infected with Sendai virus
(SenV), an RNA virus that accurately models HCV activation of
RIG-I signaling (Saito et al., 2008). In mock-infected cells,
calnexin and MFN2 were distributed within fractions 2 and 3,
reflecting their membrane association, while tubulin was present
only in fractions 5–7, demonstrating an effective separation of
total membrane from the cytosolic compartments (Figure 1A).
We noticed that, compared to resting cells, mitochondrial
markers in SenV-infected cells, such as Cox-1 and VDAC,
shifted from fractions 2–5 to fraction 2. This difference might
be due to altered context of mitochondria during viral infection,
as mitochondria elongate during infection (Castanier et al.,
2009; Horner et al., 2011), resulting in additional membrane
surface and altered density. RIG-I was exclusively present within
the cytosolic fractions of mock-infected cells. However, within
4 hr of SenV infection RIG-I appeared in the membrane fractions
and was present there through the 24 hr analysis. RIG-I similarly
redistributed to membrane during acute SenV infection of
293 cells (see Figure S1A online). We further evaluated the
distribution of YFP-RIG-I expressed in Huh7 cells. Fluorescence
microscopy analysis showed that YFP-RIG-I distributed
throughout the cytosol in mock-infected cells but was rapidly
redistributed to a perinuclear pattern during an acute SenV infec-
tion time course (Figure 1B). The redistribution of RIG-I coincided
with induction of the innate immune response as marked by the
phosphorylation/activation of IRF-3 (see Figure S2B, lanes 1–3).
We examined the extent of YFP-RIG-I redistribution in mock-
infected Huh7 cells or after 24 hr of infection with SenV, corre-
sponding to the peak of innate immune induction (Horner et al.,
2011). In mock-infected cells, YFP-RIG-I was distributed
throughout the cytoplasm and bounded by the plasma
membrane (Figure 1C, vectors I and II). In contrast, YFP-RIG-I
redistributed to concentrate within a perinuclear membranous
pattern during acute SenV infection (Figure 1C, vectors III and
IV) wherein a significant majority of infected cells exhibited this
pattern of YFP-RIG-I redistribution (Figure 1C). We observed
a similar cytosol-to-membrane redistribution of YFP-RIG-I
during acute SenV-infection of PH5CH8 hepatocytes that
corresponded to the temporal activation of IRF-3 and induction
of IFIT1 expression (Figure S1B) (Ikeda et al., 1998). Taken
together, these results demonstrate that innate immune
signaling is coupled to RIG-I cytosol-to-membrane redistribution
during acute RNA virus infection.
We next assessed RIG-I distribution during acute HCV infec-
tion in Huh7 cells expressing Flag-RIG-I. Immunoblot analysis
of membrane flotation fractions revealed that a portion of RIG-I
redistributed to membrane fractions within 4 hr of HCV infection
(Figure 1D). RIG-I membrane association was also observed in
Huh7 cells harboring a subgenomic HCV replicon RNA (Fig-
ure 1E). We therefore evaluated whether or not HCV PAMP
RNA is sufficient to stimulate the intracellular redistribution of
RIG-I. Huh7 cells expressing Flag-RIG-I were transfected with
in vitro-transcribed RNA containing 50-ppp and encoding theCell Hpoly-U/UC PAMP or the nonstimulatory X region RNA motif of
the HCV RNA genome (Saito et al., 2008). RIG-I distribution
among gradient fractions was then evaluated by immunoblot
analysis. Remarkably, Flag-RIG-I exhibited redistribution to
membrane fractions within 10 min, peaking at 1 hr, and reaccu-
mulating in the cytosol fractions by 4 hr after cells were trans-
fectedwith poly-U/UCPAMPRNAbut not X-region RNA (Figures
1F and 1G). The redistribution of RIG-I corresponded with an
accumulation of poly-U/UC PAMP but not X-region RNA within
the membrane fraction of transfected cells (Figure S1C), reflect-
ing the formation of PAMP RNA/RIG-I complex and further
demonstrating RIG-I ligand-binding specificity (Saito et al.,
2008). These results reveal that ligand binding by RIG-I triggers
its cytosol-to-membrane redistribution during acute HCV infec-
tion and demonstrate that RIG-I redistribution is triggered upon
binding to PAMP RNA.
Requirements for RIG-I Membrane Association
Recent studies show that RIG-I is recruited to the MAM where it
binds MAVS to initiate innate immune signaling (Horner et al.,
2011). To determine if RIG-I redistribution was dependent on
MAVS, we evaluated the subcellular distribution of RIG-I within
Huh7 cells stably expressing a nontargeting vector shRNA (NT-
Huh7) or shRNA targeting MAVS. In both cell lines RIG-I was re-
localized to themembrane fractions within 4 hr and through 24 hr
postinfection with SenV (Figure 2A), indicating that MAVS is not
required for RIG-I relocalization andmembrane association. This
finding is consistent with the presence of membrane-associated
RIG-I in HCV replicon cells (Figure 1E), in which MAVS is cleaved
from the MAM by the HCV protease NS3/4A during chronic HCV
replication (Horner et al., 2011; Loo et al., 2006). It is therefore
likely that RIG-I is recruited to a membrane domain prior to inter-
acting with MAVS during viral infection.
To define the requirements for RIG-I redistribution, we as-
sessed the subcellular distribution of Flag-tagged wild-type
(WT) and mutant RIG-I constructs expressed in Huh7 cells.
Because RIG-I is held in an inactive conformation in the absence
of bound RNA ligand (Jiang et al., 2011; Saito et al., 2007), ectop-
ically expressed WT Flag-RIG-I does not mediate significant
signaling in the absence of virus infection and thus maintains
its cytosolic location (Figure 2B). These observations also imply
that the membrane relocalization of RIG-I during acute viral
infection is not merely driven by an increase in RIG-I abundance
that results from innate immune signaling. However, WT Flag-
RIG-I redistributed to a membrane association within 1 hr of
SenV infection (Figure 2B). Moreover, Flag-RIG-I 1-734, which
is truncated to lack the RD and is constitutively active in signaling
(Saito et al., 2007), was membrane associated when expressed
in Huh7 cells regardless of virus infection (Figure 2B). In contrast,
the RNA-binding-defective mutant, Flag-RIG-I K888/907A
(Takahasi et al., 2008), failed to redistribute to membrane frac-
tions after SenV infection. Importantly, RIG-I T55I and K172R
mutants, which are essential for TRIM25 binding and ubiquitina-
tion (Gack et al., 2007), also failed to redistribute upon SenV
infection (Figure 2B). Thus, inactive or ‘‘signaling-off’’ RIG-I
resides in the cytosol, but upon activation during acute virus
infection RIG-I translocates to a membrane compartment in
a manner dependent upon RNA binding and controlled by the
RD, TRIM25 interaction, and K172 ubiquitination.ost & Microbe 11, 528–537, May 17, 2012 ª2012 Elsevier Inc. 529
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Figure 1. Translocation of RIG-I during Acute Virus Infection
(A) Acute SenV infection. Membrane markers were monitored with RIG-I after 4 and 24 hr of infection of Huh7 cells. Fraction numbers and their gradient positions
are noted at the top. Fractions 2 and 3 contain membranes. Fractions 5–7 contain cytosol.
(B) Redistribution of YFP-RIG-I over an acute time course of SenV infection.
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A Translocon Controls RIG-I Antiviral ActivityWe found that TRIM25 was typically distributed within both
cytosol and membrane fractions in either Huh7 cells that encode
WT RIG-I or Huh7.5 cells that encode the T55I RIG-I mutant
regardless of virus infection, suggesting that TRIM25 localization
itself is not regulated through interaction with RIG-I (Figure S2A),
though membrane-associated TRIM25 may be involved in other
processes which operate independently of RIG-I signaling. We
conducted membrane flotation analysis of NT-Huh7 cells and
TRIM25 knockdown stable Huh7 cells to assess whether
TRIM25 is required for RIG-I relocalization during viral infection.
As shown in Figure 2C, loss of TRIM25 expression resulted in
abrogation of virus-induced cytosol-to-membrane redistribution
of RIG-I. Furthermore, in TRIM25-knockdown Huh7 cells, consti-
tutively active Flag-N-RIG (see Figure 3B; Sumpter et al., 2005)
remained localized in the cytosol (Figure 2D). The absence of
TRIM25 but not MAVS expression resulted in an inability of
YFP-RIG-I to redistribute from cytosol to membrane upon
SenV infection (Figure 2E). In mock-infected NT-Huh7 cells,
RIG-I distributed to the cytosol, with TRIM25 distributed in
both cytosol and membrane compartments (Figure 2C). We
found that virus-induced RIG-I redistribution was followed by
induction of IRF-3 phosphorylation in NT-Huh7 cells, but not in
TRIM25-knockdown Huh7 cells (Figure S2B). Thus, TRIM25 is
necessary for virus-induced RIG-I translocation and innate
immune signaling. Since the constitutive membrane distribution
of TRIM25 itself is not sufficient to confer cytosol-to-membrane
redistribution of RIG-I (see Figure 2C; Figure S4), the transloca-
tion activity of the RIG-I/TRIM25 complex is likely mediated by
additional components of a RIG-I translocation complex or
‘‘RIG-I translocon.’’
14-3-3ε Is an Essential Component of the RIG-I
Translocon
To identify additional components that might participate in the
cytosol-to-membrane translocation of a RIG-I translocon, we
conductedmass spectrometry analysis to define proteins recov-
ered within anti-Flag immunoprecipitation of extracts from
Huh7 cells expressing Flag-N-RIG or irrelevant Flag-tagged
protein. A known mitochondrial targeting chaperone protein,
14-3-3ε (Dougherty and Morrison, 2004), was identified by pro-
teomics analysis of recovered proteins that specifically associ-
ated with Flag-N-RIG but not with irrelevant Flag-control
(Table S1). In coimmunoprecipitation experiments using anti-
RIG-I antibody, we confirmed that 14-3-3ε could form a complex
with RIG-I that was further enhanced by SenV infection
(Figure 3A). Remarkably, we also found that this complex
contained increasing amounts of TRIM25 during the course of
infection. RIG-I and 14-3-3ε could bind to TRIM25 in a similar
virus-induced manner, as revealed by immunoblot analysis
of anti-TRIM25 immunoprecipitation products (Figure 3A).
TRIM25 is known to bind to 14-3-3s, a ubiquitin and ISG15 ligase
(Zhang and Zhang, 2011), suggesting it may bind to a variety of(C) Intracellular distribution of YFP-RIG-I (green) in mock-infected cells and in cel
the vector marked in each fluorescent micrograph (white arrow) spanning from n
RIG-I redistribution during acute virus infection. Error bars represent ± standard
(D) Gradient position of Flag-RIG-I in Huh7 cells after mock infection or 4 hr HCV
(E) RIG-I distribution in gradients from Huh7-HCV replicon (SGR-JFH1) cells.
(F and G) (F) Gradient position of Flag-RIG-I in Huh7 cells 10 min to 4 hr after tra
Cell H14-3-3 isoforms. To evaluate TRIM25 interaction specificity with
14-3-3ε, we conducted anti-TRIM25 coimmunoprecipitation and
immunoblot analysis of extracts from Huh7 cells coexpressing
Myc-TRIM25 and Flag-14-3-3ε, 14-3-3h, or 14-3-3s (binding
control). As shown in Figure S3A, 14-3-3ε formed a stable
virus-induced complex with TRIM25, whereas 14-3-3h and
14-3-3s exhibited constitutive TRIM25 binding. These results
demonstrate that RIG-I, 14-4-3ε, and TRIM25 interact and form
a complex during acute virus infection.
To define the site(s) of 14-3-3ε binding within RIG-I, and to
determine if RIG-I, 14-4-3ε, and TRIM25 form a virus-inducible
ternary complex, we assessed Myc-14-3-3ε binding to WT
Flag-RIG-I and various Flag-RIG-I mutants in mock-infected
or SenV-infected cells. Neither 14-3-3ε nor TRIM25 could bind
to RIG-I K888/907A, indicating that PAMP RNA binding and
resulting conformational change of RIG-I promote formation of
the translocon (Figure 3C). Importantly, while 14-3-3ε bound effi-
ciently to RIG-I S8A phosphorylation mutant (Figure 3E) (Nistal-
Villan et al., 2010), the interactions of 14-3-3ε with RIG-I T55I
or RIG-I K172R were impaired (Figure 3C). As the latter two
RIG-I mutants lack the ability to bind or to be ubquitinated by
TRIM25, respectively (Gack et al., 2007, 2008), TRIM25 binding
and modification of RIG-I are thereby essential to stabilize the
interaction of RIG-I with 14-3-3ε, suggesting that the proteins
can form a ternary complex. To confirm that 14-3-3ε, RIG-I,
and TRIM25 form a virus-inducible ternary complex, Myc-14-3-
3ε and Flag-RIG-I were coexpressed and coimmunoprecipitated
by anti-Flag antibody. The immunoprecipitates were then eluted
by Flag peptide competition and then further subjected to
a second round of immunoprecipitation with anti-Myc antibody.
After two rounds of immunoprecipitation, 14-3-3ε, RIG-I, and
TRIM25 were recovered in a stable complex (Figure 3D), indi-
cating ternary complex formation in response to acute virus
infection. Furthermore, 14-3-3ε bound only to WT Flag-RIG-I
and N-RIG, and binding required the RIG-I CARDs but neither
the helicase domain nor the RD (Figure 3E).
To determine if 14-3-3ε plays a specific role in RIG-I transloca-
tion during virus infection, we monitored distribution of 14-3-3ε
and 14-3-3s (as a control) from membrane flotation analysis.
14-3-3s was only found in the cytosolic fractions of cells; in
contrast, 14-3-3εwas localized to both membrane and cytosolic
fractions regardless of infection (Figure 3F). We note that
a preliminary proteomics analysis of cell fractions showed that
14-3-3ε and TRIM25, but not 14-3-3s, are components of
MAM and ER in Huh7 cells (data not shown). These results
are consistent with previous studies of 14-3-3ε which define it
as a MAM/mitochondrial-targeting chaperone protein, and
indicate that 14-3-3ε is a component of the RIG-I translocon
(Aslan et al., 2009). Indeed, SenV infection could induce IRF-3
phosphorylationin 14-3-3s-knockdown Huh7 cells, but not in
14-3-3ε-knockdown Huh7 cells (Figure S3B), demonstrating
the specificity of 14-3-3ε function in RIG-I-dependent signaling.ls 4 hr after SenV infection. Graphs show the levels of YFP-RIG-I present along
ucleus to plasma membrane. Relocalization index demonstrates a significant
deviation.*p < 0.05.
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Figure 2. Requirements for RIG-I Translocation
(A–D) Protein distribution across membrane flotation gradients was monitored by immunoblot assay. (A) NT-Huh7 and MAVS-knockdown Huh7 cells after 4 or
24 hr SenV infection or mock infection. (B) Distribution of WT or mutant Flag-RIG-I in Huh7 cells after 1 hr of mock infection (left) or SenV infection (right). Arrows
denote positions of Flag-RIG-I 1-734. (C) Distribution of endogenous RIG-I and TRIM25 from within TRIM25 knockdown (upper) and NT-Huh7 cells (lower). Cells
were mock infected (left) or infected with SenV for 4 or 24 hr prior to harvest. The same blots were stripped and reprobed to detect RIG-I and TRIM25. (D)
Distribution of constitutively active Flag-N-RIG mutants expressed in NT control or TRIM25-knockdown Huh7 cells.
(E) Distribution of YFP-RIG-I (green) and tubulin (blue) in NT control, MAVS-knockdown, and TRIM25-knockdown Huh7 cells. Mock-infected SenV-infected cells
were imaged by confocal microscopy and analyzed for fluorescence intensity across the sections indicated by white vectors.
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Figure 3. 14-3-3ε Is a RIG-I Binding Partner in a RIG-I Translocon Containing TRIM25
(A) Complex formation between endogenous RIG-I, 14-3-3ε, and TRIM25. The recovered products from each immunoprecipitation reaction (IP) or input extract
(lysate) were analyzed by immunoblot assay for RIG-I, TRIM25, and 14-3-3ε.
(B) RIG-I mutants used in (C) and (E). Domain structure of RIG-I is shown with sites of the specific mutations. The region encoding the N-RIG construct is in
brackets.
(C) Impaired 14-3-3ε interaction of RIG-I point mutants. HEK293 cells expressing Flag-taggedWT or mutant RIG-I were coexpressed withMyc-14-3-3ε, and cells
were infected with 0–200 HAU SenV for 16 hr follwed by anti-Flag immunoprecipitation of cell extracts. The products were immunoblotted with anti-TRIM25 or
anti-Myc antibody.
(D) Anti-Flag immunoprecipitates of RIG-I (WT) from (C) were eluted and subjected to anti-Myc immunoprecepitation.
(E) Mapping of the 14-3-3ε binding domain in RIG-I. Flag-tagged WT RIG-I or RIG-I mutants were coexpressed with Myc-14-3-3ε in 293 cells. Cells were mock
infected () or infected with SenV (+). Cell extracts were subjected to immunoprecipitation with anti-Flag antibody, and products were analyzed by immunoblot
with anti-Myc antibody for 14-3-3ε.
(F and G) Distribution across membrane flotation gradients was monitored by immunoblot assay. Cells were mock infected or infected with SenV for 4 or 16 hr
prior to harvest. (F) Distribution of endognous 14-3-3s and 14-3-3ε from Huh7 cells. (G) Distribution of RIG-I, 14-3-3ε, and TRIM25 in NT- or 14-3-3ε-knockdown
Huh7 cells.
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Figure 4. 14-3-3ε Is Essential for Antiviral Signaling Activity of the RIG-I Translocon
(A and B) Ectopic expression of both 14-3-3ε and TRIM25 in (A) Huh7 and (B) HEK293 cells enhanced IFN-b promoter activity and ISG56mRNA expression during
SenV infection.
(C) IFN-b promoter activity in NT control, 14-3-3ε-knockdown, or TRIM25-knockdown 293 cells 24 hr after SenV infection.
(D) VSV-GFP-positive cells of 14-3-3s-knockdown, 14-3-3ε-knockdown, or TRIM25-knockdown Huh7 cells were anlyzed by flow cytometryafter 12 hr of VSV-
GFP infection at moi 0.01.
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Cell Host & Microbe
A Translocon Controls RIG-I Antiviral ActivityWe therefore assessed membrane association of RIG-I during
SenV infection of NT-Huh7 cells and in 14-3-3ε-knockdown
cells. In NT-Huh7 cells, the relocalization of RIG-I from cytosol
to membrane occurred within 24 hr of infection, but RIG-I trans-
location failed to occur in 14-3-3ε-knockdown cells (Figure 3G).
Moreover, when expressed in 14-3-3ε-knockdown cells, YFP-
RIG-I failed to redistribute during SenV infection (Figure S3C).
These results indicate that 14-3-3ε forms an essential complex
with RIG-I and TRIM25 to facilitate the cytosol-to-membrane
translocation of RIG-I during acute virus infection. 14-3-3ε,
TRIM25, and RIG-I therefore comprise the RIG-I translocon.
The RIG-I Translocon Is Essential for Antiviral Innate
Immunity
To assess the role of the RIG-I translocon in controlling virus
infection, we first evaluated RIG-I signaling actions in Huh7
and HEK293 cells that ectopically coexpress 14-3-3ε and
TRIM25. The coexpression of 14-3-3ε and TRIM25 significantly
enhanced SenV signaling to the IFN-b promoter activity during
acute infection, whereas expression of either protein alone did
not enhance signaling (Figures 4A and 4B). 14-3-3ε/TRIM25 co-
expression also enhanced ISG56 mRNA induction by SenV (Fig-
ure 4A). Thus, 14-3-3ε and TRIM25 cooperatively serve as
accessory proteins of RIG-I signaling. We also assessed the
IFN-b promoter activity during SenV infection of 14-3-3ε-knock-
down cells. As shown in Figure 4C, innate immune signaling was
attenuated in both 14-3-3ε- and TRIM25-knockdown cells but
remained intact in the NT control HEK293 cells. Additionally, in
HEK293 and Huh7 cells expressing either NT shRNA or shRNA
targeting 14-3-3s, N-RIG expression induced robust signaling
to the IFN-b promoter, but signaling was specifically blunted in
14-3-3ε- or TRIM25-knockdown Huh7 cells (Figures S4A and
S4B). This decrease in IFN-b promoter activity correlated with
increased susceptibility to infection with vesicular stomatitis
virus-expressing GFP (VSV-GFP) of both 14-3-3ε and TRIM25-
knockdown cells as compared to NT control cells (Figure 4D).
Importantly, when infected with HCV, 14-3-3ε-knockdown or
TRIM25-knockdown Huh7 cells both exhibited significantly
enhanced permissiveness for infection as compared to NT-
Huh7 cells (Figure 4E). Thus, the RIG-I translocon is essential
for innate immune signaling and host defense against RNA virus
infection. To define the level within the RIG-I pathway at which
14-3-3ε and TRIM25 operate, we evaluated IFN-b promoter
signaling in 14-3-3ε- or TRIM25-knockdown Huh7 cells upon
ectopic expression of N-RIG, MAVS, or constitutively active
IRF-3 (IRF-3-5D). In contrast to N-RIG, and despite the fact
that MAVS signaling was decreased in14-3-3ε-knockdown cells,
both MAVS and IRF-3-5D could signal to the IFN-b promoter in
the absence of 14-3-3ε or TRIM25 expression (Figures S4B–
S4D). We note that the reduction in signaling by ectopic MAVS
could reflect an additional as-yet-uncharacterized role for 14-(E) Levels of HCV-infected cells in cultures of NT-, 14-3-3ε-knockdown, or TRIM2
HCV infection.
(F) 14-3-3ε is required for K63 ubquitination of the RIG-I CARDs. Flag-N-RIGwas c
NT control or 14-3-3ε-specific siRNA. Cell extracts were subject to immunopre
evaluated by anti-HA immunoblot, quantified using ImageJ software, and expres
standard deviation. *p < 0.05; **p < 0.01.
(G) Model of RIG-I translocon assembly and function.
Cell H3-3ε in MAVS-specific signaling processes that are independent
of RIG-I. Together these results imply that, like TRIM25, 14-3-3ε
is essential for RIG-I signaling of innate immunity, and that 14-3-
3ε and TRIM25 both operate within the RIG-I pathway at a point
between RIG-I and MAVS to direct downstream signaling from
the level of RIG-I itself.
14-3-3ε is known to modulate ubiquitin ligase activity (Nagaki
et al., 2006). Since TRIM25 functions as the E3 ubiquitin ligase of
K63-linked ubiquitination of the RIG-I CARDs for signaling acti-
vation (Gack et al., 2007), we evaluated the role of 14-3-3ε in
regulating the ubiquitination of Flag-N-RIG when coexpressed
with HA-tagged K48 or K63 ubiquitin in NT-Huh7 control cells
or 14-3-3ε-knockdown cells. Immunoblot analysis of anti-Flag
immunoprecipitation products recovered from the cell extracts
revealed differential levels of N-RIG-ubiquitin products. Whereas
N-RIG-K63 ubiquitin products were overall reduced in 14-
3-3ε-knockdown cells, N-RIG-K48 ubiquitin products remained
unchanged between NT-Huh7 and 14-3-3ε-knockdown cells
(Figure 4F). Notably, the reduction of N-RIG-K63 ubiquitin prod-
ucts corresponds with the loss of immune signaling and
enhanced permissiveness to virus infection imposed by loss of
14-3-3ε expression in knockdown cells (compare Figures 4A–
4E). These results indicate that 14-3-3ε interaction with RIG-I
serves to stimulate or stabilize TRIM25 modification of the
RIG-I translocon by promoting RIG-I-K63 ubiquitination, translo-
con interactions, and innate immune signaling.
DISCUSSION
RIG-I translocation to theMAM/mitochondrial interface is essen-
tial for MAVS interaction, downstream activation of IRF-3 (Horner
et al., 2011), and the onset of innate antiviral immunity. Our
results reveal that this process ismediated through aRIG-I trans-
locon involving 14-3-3ε, TRIM25, and ubiquitination of RIG-I. 14-
3-3 proteins are involved in a wide range of cellular processes by
serving as scaffold or chaperone proteins (Muslin et al., 1996;
Yang et al., 2006). In particular, 14-3-3ε facilitates the cyto-
plasm-to-mitochondrion membrane shuttling of BAD and BAX
(Nomura et al., 2003). Our results now define 14-3-3ε as an
essential cofactor of the membrane distribution of RIG-I for
immune signaling against RNA viruses. RIG-I activation is initi-
ated upon binding of PAMP RNA to release RD autorepression
of CARD signaling (Saito et al., 2007). Our results infer that RD
control of CARD exposure also promotes interaction with 14-3-
3ε and TRIM25 for translocon formation. In the case of HCV,
this process occurs minutes after cell expression of PAMP
RNA (Figure 1). We propose that RIG-I modification by TRIM25
serves to sustain its ‘‘signaling-on’’ conformation initiated by
ligand binding to the RD, and that 14-3-3ε then facilitates stable
RIG-I-TRIM25 interaction/ubiquitination of RIG-I (Gack et al.,
2007) and translocon activity to bind MAVS for downstream5-knockdown-Huh7 cells were determined by focus-forming assay after 48 hr
oexpressed with HA-tagged K48 or K63 ubiquitin in Huh7 cells transfectedwith
cipitation with anti-Flag antibody. Ubiquitination level of N-RIG products was
sed as a value relative to the corresponding NT control. Error bars represent ±
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biochemical and structural models of RIG-I activation (Jiang
et al., 2011; Saito et al., 2007). Governance of RIG-I translocon
activity by PAMP RNA binding, K63 ubiquitination, and 14-3-3ε
chaperone function offers multiple checkpoints for control of
the immune response.
RIG-I is the prototypical member of the RLR family, which also
includes melanoma differentiation-associated gene 5 (MDA5)
and laboratory of genetics and physiology 2 (LGP2). While
MDA5 has been shown to act as an essential PRR for recognition
of specific viruses both independently of and cooperatively
with RIG-I, LGP2 serves as a regulator of RLR signaling (Komuro
and Horvath, 2006; Saito et al., 2007; Satoh et al., 2010).
Similar to RIG-I, MDA5 and LGP2 are cytosolic proteins and
effect innate immune signaling control throughMAVS interaction
(Loo and Gale, 2011), which is expected to involve their cyto-
sol-to-membrane redistribution. One scenario for this redistribu-
tion is that the RLRs share a common process of virus-induced
translocon assembly and function that is triggered by ligand
binding and regulated by signaling-adaptor protein interaction.
As 14-3-3 proteins themselves can function as signaling-adaptor
proteins whose actions are modified by their phosphorylation
state, it is possible that RIG-I translocon assembly is further gov-
erned by 14-3-3ε phosphorylation or other modifications
(Dougherty and Morrison, 2004). In this sense, translocon
assembly could be responsive to a variety of virus-induced
signals that serve to trigger or enhance innate immunity. In addi-
tion to altering protein localization, the 14-3-3 proteins are also
involved in modulating enzymatic activity and regulating protein
modification (Dougherty andMorrison, 2004), consistent with the
function of 14-3-3ε in promoting RIG-I ubiquitination by TRIM25
and supporting translocon activity. Moreover, 14-3-3 proteins
have been implicated in pathogen resistance of bothmammalian
and plant cells (Brandt et al., 1992; Ohman et al., 2010). Together
with our current observations, these studies implicate a broad
role for 14-3-3 family proteins in eukaryotic innate immunity.
Regulation of innate immunity and RIG-I signaling controls the
outcome of RNA virus infection and immunity (Loo and Gale,
2011). RIG-I signaling is induced during acute HCV infection as
the virus spreads from cell to cell in the liver, wherein it drives
a hepatic innate immune response aimed at suppressing HCV
infection (Liu and Gale, 2010). To evade hepatic immunity,
HCV directs the proteolysis of MAVS by the viral NS3/4A
protease to release it from the MAM and ablate RIG-I signaling,
thus abrogating the innate immune actions of RIG-I (Horner et al.,
2011; Loo et al., 2006; Saito et al., 2008). Other studies show that
HCV core protein can interact with 14-3-3ε to induce Raf-1
kinase activity and to regulate the release of BAX frommitochon-
dria, thereby imposing control of host cell signaling and
apoptosis (Aoki et al., 2000; Lee et al., 2007). These observations
underscore an important role for 14-3-3ε in HCV infection and
pathogenesis. Other pathogenic RNA viruses also target RIG-I
or its signaling partners for regulation and immune evasion
(Loo and Gale, 2011). A notable example is influenza A virus, of
which the NS1 protein of certain strains can bind to RIG-I to
disrupt complex formation with TRIM25 and block innate
immune signaling (Gack et al., 2009), suggesting that it may
disrupt the actions of the RIG-I translocon. Targeting 14-3-3ε
function and virus-responsive signaling networks of RIG-I trans-536 Cell Host & Microbe 11, 528–537, May 17, 2012 ª2012 Elsevier Ilocon regulation may therefore offer attractive therapeutic strat-
egies to modulate immune signaling for the control of RNA virus
infection.
EXPERIMENTAL PROCEDURES
Cells
Huh7 and Huh7.5 (human hepatoma) and HEK293 cells have been described
(Saito et al., 2008). MAVS, TRIM25, 14-3-3ε, and 14-3-3s-knockdown cells
were produced through transduction and selection of cells with gene-specific
pLKO.1-puro vector-based shRNA expression cassettes purchased from
Sigma.
Mass Spectrometry and Protein Identification
Products recovered from immunoprecipitation reactions of cell extracts were
processed for peptide analysis, and peptides were separated by nano-HPLC
using a 5 cm Magic C18 Column (Michrom Bioresources, Auburn, CA) using
a buffer system of (A) water + 0.1% formate and (B) acetonitrile + 0.1% formate
(Avantor Performance Materials, Phillipsburg, NJ) in 60 min gradient from 98%
A/2% B to 5% A/95% B. Peptides were detected using a linear ion trap mass
spectrometer (LTQ, Thermo Fisher Scientific). An initial mass scan from 400 to
2,000m/z was followed by four data-dependent collision-induced dissociation
MS/MS scans for peptide identifications. Normalized collision energy of 35%
was used for CID. MS/MS data were searched against the human IPI v3.28
database using SEQUEST. The results of these searches were analyzed using
Peptideprophet and Proteinprophet to determine the likelihood of a confident
protein identification. Only proteins with a probability greater than 0.95 were
considered.
Membrane Flotation Assay
Membrane preparation was performed as previously described (Liu et al.,
2009). Cell lysates in 0.5 ml of hypotonic buffer were mixed with 3 ml of 72%
sucrose in low-salt buffer (LSB) and overlaid with 4 ml of 55% sucrose in
LSB, followed by addition of 1.5 ml of 10% sucrose in LSB and centrifugation
at 38,000 rpm in a Beckman SW41Ti rotor for 14 hr at 4C. Fractions were
collected from the top of the gradient, diluted with PBS, and further concen-
trated by an Amicon YM-30 filter unit (Millipore).
Virus Infection
Huh7cellswere cultured infectedwithSenV,HCV (strainHCV2a/JFH1) (Wakita
and Kato, 2006), or VSV-GFP (Loo et al., 2006) in serum-free media at 37C.
One hour later, the cells were rinsed in PBS and incubated in media containing
10% FBS. At the time of harvest, cells were washed twice with PBS and fixed
in 3% paraformadehyde:PBS solution. Cells were immunostained with anti-
HCV serum or visualized for GFP as described (Loo et al., 2006).
Additional methods are found in the Supplemental Information.
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures, one table, and Supple-
mental Experimental Procedures and can be found with this article online
at doi:10.1016/j.chom.2012.04.006.
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